On March 30, 2010
The FTC Is Losing Its War on Expensive Drugs — But Doesn’t Know It Yet
To hear the chairman of the FTC tell it, he’s winning the battle against “pay-for-delay” deals that can keep generic competition to expensive drugs out of the market for years. But a look at recent court rulings suggests the opposite
…
0 Comments